Bexa is a new medical device that employs pressure elastography to produce high resolution images of abnormal breast tissue, and collects data about the nature, size, and location of abnormal breast tissues.
An examination of the breast with Bexa is quick, painless, involves no radiation and provides women with an immediate result. Bexa is small and portable allowing Bexa exams to be performed anywhere a woman be examined privately.
Bexa’s advanced, proprietary capacitive sensor array collects data about abnormal tissues based upon their elastic nature - how firm they are compared to surrounding tissue. These differences in tissue firmness are captured digitally when the Bexa sensor array is pressed gently against the surface of the breast. No radiation or energy of any sort is emitted by the sensor.
Bexa fully integrates the evaluation of breast masses using focused B-mode ultrasound, adding critical data to the evaluation and classification of abnormal breast tissues and dramatically reducing an already low need for additional imaging studies.
Bexa’s proprietary pressure sensor array is a critical component of the device and is unique, setting a standard as the original high-definition capacitive pressure sensor array, and since 2006 has continuously evolved adding improvements in accuracy and precision. Not all sensor arrays are equal, and the Bexa array has no peer.
Bexa adds and fully integrates high frequency linear ultrasound (5-15 MHz) images of abnormal breast masses into a consolidated, data-rich breast tissue evaluation.
The Bexa sensor array samples breast tissue elasticity measurements over 10,000 times per second in order to define tissue detail. The unique and proprietary algorithms that process and analyze these signals were created by experts in fractional calculus, soft tissue mechanics, artificial intelligence, data analysis, and machine learning and power our ability detect even small masses easily and in real-time.
All Bexa elastography and ultrasound data is automatically fed into our proprietary ML/AI engine which is continuously improving our image analysis and anomaly-detection algorithms.
All Bexa devices operate within a secure, HIPAA/HITECH-compliant, cloud-based ecosystem, SureView, which provides device management and continuous quality monitoring while contributing de-identified clinical data to a unique instance of the world’s most powerful clinical research database.
Our focus is upon outcomes, not just the technology. We spend great energy and time understanding the needs and wants of our customers, and how to provide the best exam experience. Our Referral Support Team helps women who have masses discovered and are having trouble getting timely follow-up doctors appointments, get those appointments. Real people, experienced nurses, live and on the phone, not a “chat” or overseas “customer support.” Our Telemedicine Platform allows women who have questions about exam results, to speak with a doctor at the time of their exam.
Bexa is a Class II FDA cleared (K181672) Class II medical device that is currently indicated for the documentation of masses discovered on a breast examination. Multiple U.S. clinical studies either completed or nearing completion that define Bexa’s ability to discover abnormal masses, and that demonstrate our social and economic impacts. For more information about the clinical performance of Bexa, contact our clinical team. Detail of our FDA clearance can be found here.Contact Our Clinical Team